Telomeres, Telomerase and Cancer [Reprint]

An unusual enzyme called telomerase acts on parts of chromosomes known as telomeres. The enzyme has recently been found in many human tumors and is being eyed as a new target for cancer therapy















Share on Tumblr

To develop agents that will block telomerase in the human body, investigators must also have a sharper picture of exactly how the enzyme functions. How does it attach to DNA? How does it "decide" on the number of telomeric subunits to add? DNA in the nucleus is studded with all manner of proteins, including some that specifically bind to the telomere. What part do telomerebinding proteins play in controlling the activity of telomerase? Would altering their activity disrupt telomere elongation? Within the next 10 years we expect to learn a great deal about the interactions among the various molecules that influence telomere length.

Research into the regulation of telomere size could also yield benefits beyond new therapies for cancer. A popular approach to gene therapy for various diseases involves extracting cells from a patient, inserting the desired gene and then returning the genetically corrected cells to the patient. Frequently, though, the extracted cells proliferate poorly in the laboratory. Perhaps insertion of telomerase alone or in combination with other factors would temporarily enhance replication capacity, so that larger numbers of therapeutic cells could be delivered to the patient.

Modern research into telomeres has come a long way from the initial identification of repetitive DNA on the ends of chromosomes in a unicellular pond dweller. Elongation of telomeres by telomerase, initially considered to be merely a "cute" mechanism by which some single-cell creatures maintain their chromosomes, has proved, as ever, to be other than it seemed. Telomerase is, in fact, the predominant means by which nucleated cells of most animals protect their chromosomal end segments. And, now, study of this once obscure process may lead to innovative strategies for fighting a range of cancers.

In the early 1980s scientists would not have set out to identify potential anticancer therapies by studying chromosome maintenance in Tetrahymena. The research on telomerase reminds us that in studies of nature one can never predict when and where fundamental processes will be uncovered. You never know when a rock you find will turn out to be a gem.

 



ABOUT THE AUTHOR(S)

CAROL W. GREIDER and ELIZABETH H. BLACKBURN began collaborating in 1983, when Greider joined Blackburn's laboratory at the University of California, Berkeley. Greider, who earned her PhD in molecular biology from U.C. Berkeley in 1987, is senior staff scientist at Cold Spring Harbor Laboratory. Blackburn holds a 1975 doctorate in molecular biology from the University of Cambridge. She has been a professor of microbiology and immunology at the University of California, San Francisco, since 1990 and department chair since 1993.


« Prev 1 2 3 4 5 6

6 Comments

Add Comment
View
  1. 1. Kerry Ingold 03:42 PM 10/5/09

    This is the type of research we are missing in todays world. The pure quest for knowledge instead of profit. They deserved this prize and more.

    Reply | Report Abuse | Link to this
  2. 2. Geompad in reply to Kerry Ingold 04:33 PM 10/5/09

    Kerry,
    You are being a bit rash or maiybe even uninformed with your statement that "this is type of research we are missing in todays world". There are several research programs at centers, such as the genome labs at Bethesda and in various departments at universities such as Duke where "the quest for knowledge" in the regulation of chromosome replication is on-going. Please note that these nobel lauerates remain in the USA because of our vigorous support of basic research.

    Reply | Report Abuse | Link to this
  3. 3. Geompad 04:36 PM 10/5/09

    Tetrahymena rules again as the queen of free living cells !!

    Reply | Report Abuse | Link to this
  4. 4. benmaomao 01:43 AM 11/21/09

    This study surely added a new dimension to our understanding of the cell, shed light on disease mechanisms, and stimulated the development of potential new therapies.

    Reply | Report Abuse | Link to this
  5. 5. sadaf 04:27 PM 8/31/10

    TELOMERASE

    Reply | Report Abuse | Link to this
  6. 6. Carrsix 12:49 AM 6/19/12

    Please let me know how I can get my sister into this therapy. She has been suffering from cancer for the last 30 years!! She is valiantly fighting for her life and I pray this my help her. Please let me know. Thank you for your wonderful work.

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital

Latest from SA Blog Network

  SA Digital

Science Jobs of the Week

Email this Article

Telomeres, Telomerase and Cancer [Reprint]

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X